Measuring the Trend of Use of Targeted Therapy and Economic Evaluation of Gefitinib for Advanced Non-Small Cell Lung Cancer (Nsclc) in Singapore
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.116
https://www.valueinhealthjournal.com/article/S1098-3015(14)02046-4/fulltext
Title :
Measuring the Trend of Use of Targeted Therapy and Economic Evaluation of Gefitinib for Advanced Non-Small Cell Lung Cancer (Nsclc) in Singapore
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02046-4&doi=10.1016/j.jval.2014.08.116
First page :
A737
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2121